Home > Openweb : Surveys

OPEN Resources... for Oncology Pharmacists and Their Team

Pharmacy Surveys

• Off-Label Compendia Survey Report, 2008
  In 2008 ACCC and Covance Market Access Services, Inc., released a final report on the "Impact of Payer Coverage and Reimbursement Policies on Off-Label Use of Anticancer Therapies." The Pharmaceutical Research and Manufacturers of America (PhRMA), and the Biotechnology Industry Organization (BIO) also helped develop the survey. Nearly half of the respondents report that their practice’s frequency of off-label use of anticancer therapies has decreased over the past five years. Coverage and reimbursement challenges were the overwhelming reason cited by oncology practices for their decreased use of anticancer therapies for off-label uses. Oncology practices that report an increase in off-label use attribute their increased utilization to the availability of more drugs that have been shown to be effective in uses that are not yet FDA-approved.
  
  
• Oncology Pharmacy Staffing and Services, 2007
  
  
• Off-Label Use of Anticancer Therapies: Physician Prescribing Trends and the Impact of Payer Coverage Policy, 2006.